NCT00766090 - Safety and Efficacy of GW685698X an Inhaled Corticosteroid Once Daily and Twice Daily for the Treatment of Asthma | Biotech Hunter

Enrollment

190

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions

Asthma

Interventions

DRUG

GW685698X

Inhaled Corticosteroid

Trial Locations (16)

20814

GSK Investigational Site, Bethesda

27607

GSK Investigational Site, Raleigh

29118

GSK Investigational Site, Orangeburg

32308

GSK Investigational Site, Tallahassee

32927

GSK Investigational Site, Cocoa

44718

GSK Investigational Site, Canton

65203

GSK Investigational Site, Columbia

65401

GSK Investigational Site, Rolla

76712

GSK Investigational Site, Waco

78006

GSK Investigational Site, Boerne

78229

GSK Investigational Site, San Antonio

78750

GSK Investigational Site, Austin

90505

GSK Investigational Site, Torrance

90806

GSK Investigational Site, Long Beach

90808

GSK Investigational Site, Long Beach

97504

GSK Investigational Site, Medford